SanBio Company Limited (OTCMKTS:SNBIF) Short Interest Up 53.7% in December

SanBio Company Limited (OTCMKTS:SNBIF) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 768,100 shares, a growth of 53.7% from the December 15th total of 499,800 shares. Based on an average daily volume of 500 shares, the days-to-cover ratio is presently 1,536.2 days.

SanBio Stock Performance

OTCMKTS:SNBIF remained flat at C$4.65 during midday trading on Thursday. SanBio has a one year low of C$4.65 and a one year high of C$5.92. The firm’s 50 day simple moving average is C$4.62 and its 200 day simple moving average is C$4.12.

About SanBio

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.